Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2017 Jul 11;26(9):1450–1458. doi: 10.1158/1055-9965.EPI-17-0264

Table 1.

Descriptive characteristics of study cohort of 24,840 women.

N (%)
FFDM machine type
 Hologic 20,877 (84.0)
 GE 3,963 (16.0)
Age, Mean (IQR) 61.5 (56.0–68.0)
BMI (kg/m2), Mean (IQR) 27.6 (23.2–30.7)
Late adolescent BMI (kg/m2), Mean (IQR) 21.1 (19.3–22.3)
Menopause (based on survey)
 Pre-menopause 4,835 (19.5)
 Post-menopause 20,005 (80.5)
Menopausal Hormone Therapy in last 5 years
 No (includes pre-menopausal women) 18,680 (75.2)
 Yes 6,160 (24.8)
Parity
 Nulliparous 2,318 (9.3)
 One child 3,662 (14.7)
 Two children 9,217 (37.1)
 Three children 4,168 (16.8)
 Four or more children 2,045 (8.2)
 Missing 3,430 (13.8)
Age at first birth
 Have not given birth 2,318 (9.3)
 <20 years 2,584 (10.4)
 20–24 years 6,734 (27.1)
 25–29 years 5,502 (22.2)
 30–34 years 2,748 (11.1)
 35–40 years 1,133 (4.6)
 >40 years 252 (1.0)
 Missing 3,569 (14.4)
Age at menarche
 <10 years 491 (2.0)
 10–11 years 4,617 (18.6)
 12–13 years 13,177 (53.1)
 14–15 years 4,147 (16.7)
 >16 years 920 (3.7)
 Never had a menstrual period 10 (<0.1)
 Missing 1,478 (5.9)
Family history of breast cancer
 No 22,505 (90.6)
 Yes 2,335 (9.4)
Percent Density (%), Mean (IQR) 21.0 (8.1–31.1)
Dense Area (cm2), Mean (IQR) 28.0 (14.4–37.0)